![Michael Kaseta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 8 M $ al 31/05/2026
Michael Kaseta is currently Director at Bryn Pharma LLC since 2023, Independent Director at Heron Therapeutics, Inc. since 2024, Chief Financial & Operating Officer at Liquidia Corp.
since 2020, and Chief Financial & Operating Officer at Liquidia Technologies, Inc. since 2020.
Former roles include Independent Director at Alimera Sciences, Inc. from 2023 to 2024, Chief Financial Officer-Sanofi North America at Sanofi from 2015 to 2016, Chief Financial Officer at Aerami Therapeutics, Inc. from 2019 to 2020, and Chief Financial & Accounting Officer at Old API Wind-down Ltd. from 2018 to 2019.
Education includes undergraduate studies at James Madison University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,15 % | 23/05/2026 | 130.442 ( 0,15 % ) | 8 M $ | 31/05/2026 |
HERON THERAPEUTICS INC 0,02 % | 14/04/2026 | 29.787 ( 0,02 % ) | 25 915 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LIQUIDIA CORPORATION | Director Financiero/CFO | 30/11/2020 |
| HERON THERAPEUTICS, INC. | Director/Miembro de la Junta | 04/11/2024 |
Bryn Pharma LLC
 Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Director/Miembro de la Junta | 02/05/2023 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Director Financiero/CFO | 20/08/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| ALIMERA SCIENCES, INC. | Director/Miembro de la Junta | 16/09/2024 |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Director Financiero/CFO | 01/11/2020 |
| OLD API WIND-DOWN LTD. | Director Financiero/CFO | 01/01/2019 |
| SANOFI | Corporate Officer/Principal | 01/09/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
James Madison University
 James Madison University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
